Skip to main content
. 2019 Aug 6;12:155–166. doi: 10.2147/PGPM.S210770

Table 2.

Genotype frequency of LEP, LEPR, DRD2, HTR2A, and HTR2C polymorphisms among patients with and without impaired fasting glucose

Risperidone Clozapine
NFGa (n=90) IFGb (n=40) p-valuec OR (95% CI)d NFGa (n=18) IFGb (n=32) p-valuec OR (95% CI)d
LEP rs7799039 (G>A)
 GG 9 (100.0) 0 (0.0) 0.008 3.28 (1.44–7.50) 2 (40.0) 3 (60.0) 0.913 0.78 (0.24–2.48)
 AG 38 (79.2) 10 (20.8) 7 (31.8) 15 (68.2)
 AA 43 (58.9) 30 (41.1) 9 (39.1) 14 (60.9)
LEPR rs1137101 (A>G)
 AA 4 (100.0) 0 (0.0) 0.427 1.92 (0.84–4.36) 0 (0.0) 1 (100.0) >0.999 0.73 (0.19–2.82)
 AG 25 (71.4) 10 (28.6) 4 (33.3) 8 (66.7)
 GG 61 (67.0) 30 (33.0) 14 (37.8) 23 (62.2)
DRD2 rs4436578 (T>C)
 TT 45 (72.6) 17 (27.4) 0.116 1.35 (0.64–2.87) 8 (44.4) 10 (55.6) 0.220 1.76 (0.53–5.80)
 CT 37 (72.5) 14 (27.5) 7 (25.9) 20 (74.1)
 CC 8 (47.1) 9 (52.9) 3 (60.0) 2 (40.0)
HTR2A rs6313 (T>C)
 TT 36 (67.9) 17 (32.1) 0.964 0.90 (0.42–1.92) 9 (37.5) 15 (62.5) >0.999 1.13 (0.36–3.60)
 CT 43 (69.4) 19 (30.6) 7 (33.3) 14 (66.7)
 CC 11 (73.3) 4 (26.7) 2 (40.0) 3 (60.0)
HTR2C rs518147 (G>C)
 GG 70 (70.0) 30 (30.0) 0.269 1.17 (0.49–2.79) 13 (39.4) 20 (60.6) 0.565 1.56 (0.45–5.47)
 CG 14 (77.8) 4 (22.2) 4 (40.0) 6 (60.0)
 CC 6 (50.0) 6 (50.0) 1 (14.3) 6 (85.7)
HTR2C rs12836771 (A>G)
 AA 73 (70.9) 30 (29.1) 0.332 1.43 (0.59–3.48) 14 (37.8) 23 (62.2) 0.889 1.37 (0.35–5.30)
 AG 11 (73.3) 4 (26.7) 3 (37.5) 5 (62.5)
 GG 6 (50.0) 6 (50.0) 1 (20.0) 4 (80.0)

Notes: aNFG: normal fasting plasma glucose. bIFG: increased fasting plasma glucose. cχ2 test (Pearson chi-square or Fisher’s exact) for the genotype frequencies between NFG and IFG groups dOdds ratio (95% confidence interval): Recessive genetic model; LEP rs7799039: AA vs AG + GG; LEPR rs1137101: GG vs AG + GG. Dominant genetic model; DRD2 rs4436578: CC + CT vs TT; HTR2A rs6313: CC + CT vs TT; HTR2C rs518147: CC + CG vs.GG; HTR2C rs12836771: GG + AG vs AA.